Why the Cannabis Green Rush Crashed: Taxes, Oversupply, and the Economics Behind the Bust

Quick Answer

Legalization created demand, but it also attracted too much capital and production, pushing cannabis prices and margins lower.
Federal prohibition still creates major operating disadvantages for many state-legal cannabis businesses, including Section 280E tax restrictions and barriers to interstate commerce.
Licensed operators compete with an illicit market that does not face the same taxes, licensing fees, testing rules, or compliance expenses.
Social-equity programs opened doors for some entrepreneurs, but access to capital and regulatory complexity remain major obstacles.
Cannabis stocks and sector ETFs suffered extraordinary drawdowns after early growth expectations collided with difficult business economics.

Why the Cannabis Green Rush Crashed: Taxes, Oversupply, and the Economics Behind the Bust

Cannabis legalization once looked like one of the easiest investment stories in America. Millions of consumers already existed. More states were legalizing. Wall Street saw a huge market moving from the shadows into regulated stores. Investors saw an opportunity to get in before cannabis became another national consumer industry.

Then reality arrived with taxes, licensing costs, falling wholesale prices, limited interstate commerce, competition from unlicensed sellers, and businesses that had expanded much faster than their cash flows justified.

The result was not the disappearance of the legal cannabis industry. Legal sales remain substantial, and states such as California continue to collect billions in cannabis-related tax revenue. But the original “legalization equals easy profit” investment thesis proved badly incomplete. Demand was real. Profitable economics were much harder.

1. How Cannabis Legalization Created an Oversupply Problem

Legalization proved that cannabis had strong consumer demand. What investors underestimated was how quickly cultivation capacity could expand. When production grows faster than legal-market demand, prices fall and the companies with the highest costs feel the pressure first.

During the early Green Rush, cannabis companies raised large amounts of capital and built cultivation facilities, processing operations, brands, and retail stores. The basic assumption sounded irresistible: an enormous illegal market was becoming legal, so the companies that scaled fastest would dominate it.

But cannabis is still an agricultural product. More production eventually means more supply. California's Department of Cannabis Control reported that licensed cannabis production increased 11.8% in 2024 to roughly 1.4 million pounds, while market conditions remained difficult and prices for some wholesale and retail products stayed under pressure.

That creates a painful equation for growers. A cultivation facility has rent, electricity, labor, security, testing, licensing, insurance, and equipment costs whether wholesale cannabis sells at a premium or at a steep discount. When selling prices fall faster than operating costs, revenue growth does not necessarily translate into healthy profits.

This is one of the Green Rush's biggest lessons: high demand does not automatically create high margins. If too many businesses chase the same demand, competition can turn a booming consumer market into a miserable producer market.

2. Why Federal Law and Section 280E Still Matter

State legalization did not create a normal national industry. Federal cannabis restrictions continue to affect taxation, interstate business activity, financing, and corporate structure. Section 280E is especially important because many ordinary business deductions remain unavailable to marijuana businesses covered by the rule.

The legal cannabis market is unusual because a business can operate lawfully under state rules while still confronting federal restrictions. The broader federal process to move marijuana from Schedule I to Schedule III has remained unresolved, leaving the industry without the clean federal-state alignment investors once assumed would arrive quickly.

That matters enormously because Internal Revenue Code Section 280E applies to businesses trafficking in Schedule I or Schedule II controlled substances. The rule generally prevents affected cannabis businesses from deducting many ordinary business expenses that conventional companies routinely deduct.

There is an important distinction, however. Cannabis companies are not simply taxed on every dollar of gross revenue. The IRS permits properly calculated cost of goods sold to reduce gross receipts when determining gross income. What Section 280E restricts are many other deductions and credits associated with running the business.

For a retailer with heavy rent, payroll, marketing, administrative, security, and compliance expenses, that distinction can still produce an effective tax burden dramatically different from that of an ordinary retailer. A company may have positive accounting income before certain expenses yet struggle badly with actual cash flow after taxes and operating costs.

Federal prohibition also helps keep state markets economically fragmented. A cannabis producer in one state generally cannot operate like a national agricultural supplier shipping marijuana freely to retailers across state lines. Businesses often have to recreate cultivation, processing, distribution, and retail infrastructure state by state.

3. Why the Illicit Cannabis Market Never Disappeared

Legalization did not automatically eliminate illegal sellers. Licensed businesses must absorb taxes, product testing, licensing, security, packaging, labor, and compliance costs that illicit operators can avoid, creating a persistent price disadvantage.

One of the most optimistic arguments for legalization was that consumers would naturally migrate toward licensed stores, tested products, predictable labeling, and regulated businesses. Some clearly have. California's regulated cannabis market has generated billions of dollars in state tax revenue since recreational sales began.

But legalization did not erase the underground supply chain. California's own market analysis estimated roughly 11.4 million pounds of illicit cannabis production annually, compared with approximately 1.4 million pounds of licensed production in 2024. The figures are not a direct measure of illicit retail sales, but they illustrate how large unlicensed production remains.

The economic reason is not mysterious. A legal operator may pay licensing fees, local taxes, state taxes, testing expenses, track-and-trace costs, employee payroll, insurance, packaging expenses, rent, and regulatory-compliance costs. An illegal seller can ignore many or all of them.

That does not make illicit products equivalent. Legal markets provide testing, regulated labeling, licensed distribution, consumer protections, and tax revenue that the underground market does not. Economically, however, licensed companies still have to convince price-sensitive consumers to pay enough of a premium to cover those protections.

California has repeatedly expanded enforcement against illegal cannabis operations while also trying to reduce pressure on licensed businesses. In 2025, the state reversed a temporary increase in its cannabis excise tax and restored the rate to 15% beginning October 1, 2025, explicitly citing the need to help the legal industry compete.

4. Why Cannabis Social-Equity Programs Struggled

Social-equity programs created pathways for entrepreneurs harmed by cannabis prohibition, but receiving eligibility or a license is not the same as receiving enough capital to build a sustainable business. Funding, real estate, regulation, and investor relationships remain major obstacles.

Cannabis legalization was also presented as an opportunity to repair some of the economic damage caused by decades of marijuana enforcement. Social-equity programs in states and cities were designed to give people and communities disproportionately affected by prohibition better access to business licenses and industry opportunities.

The problem is that a license alone does not finance a business. California's Department of Cannabis Control identifies access to capital, complex regulation, suitable business locations, technical support, and business relationships among the major obstacles cannabis equity entrepreneurs face.

Research published through California's cannabis regulator has also documented concerns about outside investment arrangements in which undercapitalized equity operators can lose effective control of the businesses they were supposed to own. That creates an uncomfortable contradiction: the program can provide a valuable license while the entrepreneur still lacks the money needed to make that license economically useful.

States have responded with grants, fee relief, technical assistance, tax credits, low-interest financing, and equity-focused licensing programs. California reported more than 2,100 active equity licenses as of early 2025, showing that these programs have created real participation. The harder question is whether enough of those businesses can become sustainably profitable.

That is ultimately the same problem facing the broader industry. Legal permission is valuable, but permission does not replace working capital, healthy margins, or a viable operating model.

5. How Cannabis Stocks Lost the Green Rush Premium

Cannabis stocks were initially valued on the size of the future market. Eventually investors demanded evidence of cash flow, manageable debt, durable margins, and profitable expansion. When those results failed to match early expectations, valuations collapsed.

Few companies captured the early cannabis boom better than MedMen. Its polished retail stores helped popularize the idea that cannabis dispensaries could become premium mainstream retail destinations. The company was frequently compared with high-end consumer brands and became one of the industry's most recognizable names.

The ending looked very different. MedMen entered bankruptcy proceedings in Canada in April 2024, while its U.S. subsidiary was placed into receivership as part of a process to liquidate assets. Court filings later indicated that subsidiary liabilities were expected to substantially exceed estimated liquidation values.

The stock-market damage has extended far beyond one company. Major cannabis-focused funds remained more than 90% below their historical highs in late September 2026. The Amplify Alternative Harvest ETF, known by the ticker MJ, was roughly 94% below its historical peak, while other major cannabis funds showed similarly extreme long-term drawdowns.

Those losses do not prove that legal cannabis has no economic future. They show something different: an attractive industry does not automatically make every company in that industry an attractive investment.

Investors originally paid for expected legalization, national expansion, growing consumer acceptance, and enormous addressable markets. Over time, the market began pricing what was actually in front of it: state-by-state regulation, high taxes, constrained capital, competition, falling prices, debt, dilution, and uncertain federal reform.

Key Takeaways at a Glance

Legal cannabis demand was real, but rapid production growth and intense competition weakened pricing power.
Federal restrictions and Section 280E continue to make cannabis economics different from ordinary retail businesses.
The illicit market remains a powerful competitor because unlicensed operators avoid many costs imposed on regulated businesses.
Social-equity licenses can expand opportunity, but capital and operating barriers can determine whether those opportunities become viable businesses.
The collapse in cannabis stock valuations was largely a correction from expectations of easy, nationwide growth to the industry's much harder financial reality.

Problem	Business Effect	Why It Matters
Oversupply	Lower cannabis prices	Margins shrink even when demand remains strong
Section 280E	Limits ordinary tax deductions	Cash taxes can be unusually burdensome
Illicit competition	Legal operators face higher costs	Unlicensed sellers can compete aggressively on price
Capital barriers	Expansion becomes harder	Especially challenging for smaller and equity operators
Investor expectations	Severe valuation compression	Future growth could no longer justify earlier valuations

The Cannabis Bust Was Really a Business-Model Reality Check

The Green Rush did not fail because Americans suddenly stopped buying cannabis. The more important problem was that investors confused a large consumer market with an automatically profitable industry.

Legal cannabis businesses operate inside one of the strangest economic structures in American commerce. They can be licensed and taxed by a state while facing federal restrictions, compete with illegal businesses that avoid the regulatory system entirely, and sell a product whose wholesale price can decline rapidly when production expands.

Federal reform could eventually change important parts of that equation, especially taxation and interstate business conditions. But the experience of the past decade has already established the larger lesson. Regulation matters. Capital discipline matters. Supply matters. Competition matters. And apparently even an industry called the Green Rush eventually has to meet the deeply unfashionable requirement known as making money.